User profiles for Georgios Germanidis

Georgios Germanidis

ΕΜΒΙΕΕ (SUBRE)
Verified email at auth.gr
Cited by 6451

[HTML][HTML] Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B

…, R Jin, ZM Lu, T Piratvisuth, G Germanidis… - … England Journal of …, 2004 - Mass Medical Soc
Background Available treatments for hepatitis B e antigen (HBeAg)–negative chronic hepatitis
B are associated with poor sustained responses. As a result, nucleoside and nucleotide …

[HTML][HTML] Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

…, C Papagoras, I Mitroulis, G Germanidis… - The Journal of …, 2020 - Am Soc Clin Investig
Emerging data indicate that complement and neutrophils contribute to the maladaptive
immune response that fuels hyperinflammation and thrombotic microangiopathy, thereby …

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus …

D Lavillette, Y Morice, G Germanidis, P Donot… - Journal of …, 2005 - Am Soc Microbiol
The factors leading to spontaneous clearance of hepatitis C virus (HCV) or to viral persistence
are elusive. Understanding virus-host interactions that enable acute HCV clearance is key …

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and …

…, J Goudevenos, MS Elisaf, G Germanidis… - Metabolism, 2017 - Elsevier
Non-alcoholic fatty liver disease (NAFLD), the most common liver disease, is characterized
by accumulation of fat (> 5% of the liver tissue), in the absence of alcohol abuse or other …

Antiviral action of ribavirin in chronic hepatitis C

…, H Dahari, AU Neumann, C Hezode, G Germanidis… - Gastroenterology, 2004 - Elsevier
Background & Aims : In the patients with chronic hepatitis C, the addition of ribavirin to
interferon (IFN)-α significantly increases the virologic responses. Our aim was to assess the …

Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment

F Penin, C Combet, G Germanidis, PO Frainais… - Journal of …, 2001 - Am Soc Microbiol
Chronic hepatitis C virus (HCV) infection is a major cause of liver disease. The HCV
polyprotein contains a hypervariable region (HVR1) located at the N terminus of the second …

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101

P Skendros, G Germanidis, DC Mastellos… - Science …, 2022 - science.org
Complement C3 activation contributes to COVID-19 pathology, and C3 targeting has
emerged as a promising therapeutic strategy. We provide interim data from ITHACA, the first …

[HTML][HTML] Tumor-associated macrophages in hepatocellular carcinoma pathogenesis, prognosis and therapy

K Arvanitakis, T Koletsa, I Mitroulis, G Germanidis - Cancers, 2022 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) constitutes a major health burden, accounting
for >80% of primary liver cancers globally. Inflammation has come into the spotlight as …

Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses

…, P Hilgard, H Scherubl, ME Scheulen, G Germanidis… - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: Hepatic markers are utilized in many classification systems of patients
with hepatocellular carcinoma and, by measuring organ damage and tumor stage, can …

[HTML][HTML] Tumor-associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy

K Arvanitakis, I Mitroulis, G Germanidis - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma is the most prevalent primary liver cancer,
accounting for >80% of primary liver cancers worldwide. Inflammation has come to light as a …